Evidence map›Paper›PMID 33828998›Full record

ReviewFrontiers in cellular and infection microbiology2021

Regulatory Mechanisms of Autophagy-Targeted Antimicrobial Therapeutics Against Mycobacterial Infection.

Prashanta Silwal, Seungwha Paik, Jin Kyung Kim, Tamotsu Yoshimori, Eun-Kyeong Jo

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. HowVaccines · 2026
    Review
  4. Article
  5. IL12RB1 Deficiency Appearing in North America: Expanding the Clinical Phenotypes.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. The Role of mTOR inBiomedicines · 2024
    Review
  12. Targeting AMP-activated protein kinase in sepsis.Frontiers in endocrinology · 2024
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Host-Directed Therapies for Tuberculosis.Pathogens (Basel, Switzerland) · 2022
    Review
  18. Article
  19. Article
  20. Frontiers in immunology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Prashanta SilwalDepartment of Microbiology, Chungnam National University School of Medicine, Daejeon, South Korea.
Seungwha PaikDepartment of Microbiology, Chungnam National University School of Medicine, Daejeon, South Korea.
Jin Kyung KimDepartment of Microbiology, Chungnam National University School of Medicine, Daejeon, South Korea.
Tamotsu YoshimoriDepartment of Genetics, Graduate School of Medicine, Osaka University, Osaka, Japan.
Eun-Kyeong JoDepartment of Microbiology, Chungnam National University School of Medicine, Daejeon, South Korea.
Chungnam National University · KROsaka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Infective AgentsMycobacterium tuberculosisTuberculosisAnimalsAutophagyHumansLysosomesAnti-Infective AgentsAMPKautophagyhost-directed therapeuticsmTORMycobacterium tuberculosis

Identifiers

PMID33828998
PMCPMC8019938
OpenAlexW3136687130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.